Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in... see more

Recent & Breaking News (TSXV:VPT)

IIROC Trade Resumption - VentriPoint Diagnostics Ltd.

Newsfile January 17, 2018

Ventripoint Applies to US FDA for Market Clearance for the VMS+ Whole-Heart Analysis System

TheNewsWire January 17, 2018

IIROC Trading Halt - VPT

Canada NewsWire January 17, 2018

IIROC Trade Halt - VentriPoint Diagnostics Ltd.

Newsfile January 17, 2018

Ventripoint Appoints Head of Sales for North America

TheNewsWire January 10, 2018

IIROC Trading Resumption - VPT

Canada NewsWire January 8, 2018

Ventripoint Receives CE Mark for VMS+ Whole Heart Analysis System

TheNewsWire January 8, 2018

IIROC Trading Halt - VPT

Canada NewsWire January 8, 2018

IIROC Trade Halt - VentriPoint Diagnostics Ltd.

Newsfile January 8, 2018

Ventripoint Applies for CE Mark for VMS+ Device and Complete Heart Analysis System

TheNewsWire December 20, 2017

Ventripoint Provides Corporate Update

TheNewsWire December 19, 2017

Ventripoint Exhibits at Major Heart Imaging Conference in Europe

GlobeNewswire December 6, 2017

Ventripoint Invents a New Way to Track Ultrasound Probes that will Speed up Exams

GlobeNewswire November 27, 2017

Ventripoint Diagnostics Ltd. is Unaware of Any Material Change 

GlobeNewswire November 20, 2017

Ventripoint Establishes Partnership with the SEED Group from Dubai to Begin Deploying VMS-PLUS Heart Analysis Systems in the Middle East

GlobeNewswire November 15, 2017

Ventripoint Provides Corporate Update

MarketWire Canada September 20, 2017

Ventripoint Reports on Use of VMS Heart Analysis System to Reliably Measure Remodeling of the Right Ventricle

MarketWire Canada August 21, 2017

Ventripoint Announces Results of Annual Shareholders' Meeting and Grant of Options and DSUs

Marketwired August 16, 2017

A Third Highly Successful Ultrasound Executive joins Ventripoint

Marketwired July 20, 2017

Highly Successful Global Industry (Ultrasound) Sales & Marketing Executives Hired by Ventripoint

Marketwired June 21, 2017